Clinical-stage biopharma company develops oral therapies targeting resistant cancers, focusing on CDK inhibitors for breast cancer treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Carrick Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for aggressive and resistant forms of cancer. Its lead program, samuraciclib, is an oral CDK7 inhibitor currently in multiple Phase 2 clinical trials targeting metastatic HR+ breast cancer. Additionally, the company is advancing CT7439, a CDK12/13 inhibitor and Cyclin-K degrader, into clinical development to address various cancer types.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Carrick Therapeutics Management Team
Carrick Therapeutics Valuations & Financials
View real-time NPM data on Carrick Therapeutics stock including daily Carrick Therapeutics stock price estimates, valuation history, and historical share price information. Access Carrick Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Carrick Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Carrick Therapeutics? Get in touch to learn more.
Similar Companies
like Carrick Therapeutics
Diligent Pharma
Healthcare & Life Sciences
Centralized platform streamlining vendor qualification for clinical trials, improving speed and quality while reducing risks.
Jupiter Endovascular
Healthcare & Life Sciences
Medical technology startup developing endoportal procedures that combine catheter-based interventions with surgical-like precision and control.
ThetaRho
Healthcare & Life Sciences
Enables which clinicians retrieve and act on patient data using conversational AI to reduce administrative burden.
HD Medical
Healthcare & Life Sciences
Facilitates AI‑enhanced cardiac diagnostics which combine wearable sensors and remote patient monitoring.
TBD Health
Healthcare & Life Sciences
Offers a service that provides at-home testing and telehealth care to help individuals manage sexual health with convenient support.
Qardio
Healthcare & Life Sciences
Tracks cardiovascular health that brings blood pressure, ECG, and vital-sign monitoring together in a connected app and device ecosystem.
Cari Health
Healthcare & Life Sciences
Provides real-time drug monitoring with wearable sensors to support personalized medication dosing.
Neuro42
Healthcare & Life Sciences
Merges portable MRI, robotics, and AI to deliver on-site diagnostics and procedural support.
Promontory Therapeutics
Healthcare & Life Sciences
Biotech company develops small molecule immunotherapies that trigger immune responses against cancer through immunogenic cell death.
FAQ
We have answers
Carrick Therapeutics stock does not trade on public stock exchanges. Carrick Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Carrick Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Carrick Therapeutics Stock does not trade on public stock exchanges. In order to sell Carrick Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Carrick Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Carrick Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Carrick Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Carrick Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Carrick Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Carrick Therapeutics is a private company and has not had an IPO. There is currently no Carrick Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Carrick Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
